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Abstract
Chicken Anaemia Virus (CAV) is an economically important virus that targets lymphoid and
erythroblastoid progenitor cells leading to immunosuppression. This study aimed to investi-
gate the interplay between viral infection and the host’s immune response to better under-
stand the pathways that lead to CAV-induced immunosuppression. To mimic vertical
transmission of CAV in the absence of maternally-derived antibody, day-old chicks were
infected and their responses measured at various time-points post-infection by qRT-PCR
and gene expression microarrays. The kinetics of mRNA expression levels of signature
cytokines of innate and adaptive immune responses were determined by qRT-PCR. The
global gene expression profiles of mock-infected (control) and CAV-infected chickens at 14
dpi were also compared using a chicken immune-related 5K microarray. Although in the thy-
mus there was evidence of induction of an innate immune response following CAV infection,
this was limited in magnitude. There was little evidence of a Th1 adaptive immune response
in any lymphoid tissue, as would normally be expected in response to viral infection. Most
cytokines associated with Th1, Th2 or Treg subsets were down-regulated, except IL-2, IL-13,
IL-10 and IFNγ, which were all up-regulated in thymus and bonemarrow. From the microarray
studies, genes that exhibited significant (greater than 1.5-fold, false discovery rate <0.05)
changes in expression in thymus and bonemarrow on CAV infection were mainly associated
with T-cell receptor signalling, immune response, transcriptional regulation, intracellular sig-
nalling and regulation of apoptosis. Expression levels of a number of adaptor proteins, such
as src-like adaptor protein (SLA), a negative regulator of T-cell receptor signalling and the
transcription factor Special AT-rich Binding Protein 1 (SATB1), were significantly down-
regulated by CAV infection, suggesting potential roles for these genes as regulators of viral
infection or cell defence. These results extend our understanding of CAV-induced immuno-
suppression and suggest a global immune dysregulation following CAV infection.
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Introduction
Chicken anaemia virus (CAV) is an immunosuppressive gyrovirus of the Circoviridae family
with high prevalence, which causes severe anaemia, haemorrhages and immunosuppression in
young chickens [1–4]. Such effects reduce the efficiency of routine vaccinations, while aggra-
vating the effects of other pathogens, causing considerable economic losses to the poultry
industry [4–6]. Chickens can be infected with CAV, both vertically and horizontally [7]. Sub-
clinical disease of commercial broilers due to CAV is more common than clinical disease [3].
Vertical transmission causes clinical disease in young chicks at 10–14 days of age, resulting
in immunosuppression. Clinical disease is now controlled by ensuring that breeder flocks have
sero-converted before they come into lay, either by natural infection or vaccination. Protection
of the newly hatched chick is therefore through maternally derived antibody (MDA). Once
MDA has gone (2–3 weeks post hatch), CAV can also infect older birds by horizontal transmis-
sion resulting mainly in sub-clinical disease. Sub-clinical disease has economic, health and wel-
fare consequences, leading to lower income, higher feed conversion ratios and lower body
weight [8]. Importantly, CAV is increasing in prevalence and infection increases susceptibility
to a wide variety of other avian pathogens, both viral and bacterial, presumably through immu-
nosuppression of the CAV-infected bird [5].
CAV is one of the smallest animal viruses and as such, information on its interaction with
the host is of intrinsic scientific interest. CAV has an unusually small, circular, single-stranded
DNA genome encoding three open reading frames for a single structural protein, VP1 and two
non-structural proteins, VP2 and VP3, together with a non-coding region, which contains
gene regulatory elements. VP2 is a dual specificity protein tyrosine phosphatase [9] and VP3
(also known as “apoptin”) induces apoptosis in various human tumour and transformed cells
[10, 11]. It has been suggested that apoptosis induced by this protein is responsible for the lym-
phoid depletion caused by CAV infection [12]. Phosphorylation at threonine 108 in VP3 is
important for the nuclear localisation and cell killing ability of apoptin [13]. However, the
mechanisms of apoptin-induced cell death and the role of VP2 in the infection/replication pro-
cess are not yet clear.
The CAV virus targets lymphoid and erythroblastoid progenitor cells. CAV-induced apo-
ptosis of the precursor haemocytoblast cells leads to a decrease of erythrocytes, thrombocytes
and granulocytes, causing anaemia, haemorrhages and immunosuppression, resulting in an
increased prevalence of secondary infections [1, 4, 14]. Other sites of CAV replication are pre-
cursor T-cells in the cortex of the thymus, CD8 cells in the spleen, and to a lesser extent, the
bursa of Fabricius [1]. Within 3–4 days post-infection (dpi), viral antigens can be isolated in
the bone marrow, while maximal T-cell depletion of lymphoid organs and especially depletion
of the thymic cortex, takes place at 10–14 dpi [12, 15]. In the embryo model [9], CAV causes
thymic depletion, down-regulation of expression levels of proinflammatory cytokine mRNA in
the infected thymus (possibly explaining the lack of an inflammatory response to CAV infec-
tion) and down-regulation of Major Histocompatibility Complex (MHC) Class I mRNA
expression levels, despite moderate up-regulation of type I interferon (IFN) mRNA expression
levels (presumably thereby decreasing the infected thymocytes’ ability to present viral antigen
to any responding cytotoxic T-cells).
As suggested above, there are many aspects of the pathogenicity of CAV and the host
immune response to it, which remain unclear. For example, it is not known how the host
responds during the early stages of CAV infection, which specific signalling pathways are
involved in its pathogenesis and how the virus exploits/triggers apoptosis. The effect of CAV
infection in vitro on the transcriptome of MSB1 cells resulted in an initial wave of inflamma-
tory, anti-apoptotic and anti-viral gene expression changes followed by alterations in genes
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associated with immunosuppression [16]. In this study, we aimed to advance our understanding
of the host pathways that result in clinical disease following CAV infection in vivo. Day-old, spe-
cific-pathogen-free (SPF) chicks were infected with CAV, which mimicked vertical transmission
in the absence of MDA.Wemeasured the responses to CAV in two ways. Firstly, we determined
the kinetics of mRNA expression levels of signature cytokines of innate and adaptive immune
responses at 4, 7, 11 and 14 dpi. There have been several global transcriptomic analyses of other
viral infections of chickens [16–21]. However, few host gene expression studies have been con-
ducted so far following in vivo infection with CAV and therefore a number of key genes and
pathways involved in the pathogenesis of CAV infection may as yet be unidentified. We therefore
also compared the gene expression profiles of mock-infected (control) and CAV-infected chick-
ens at 14 dpi using a chicken immune-related 5K gene expression microarray [21].
Materials and Methods
Animal study
All animal experiments throughout this study were conducted according to the policy of the
federation of European Laboratory Animal Science Associations and the European Convention
for the protection of vertebrate animals used for experimental and other scientific purposes,
with implementation of the principles of the 3R's (replacement, reduction, refinement). Ethical
permission specifically for the experiments described here was obtained from the Queen's Uni-
versity Animal Welfare and Ethics Review Board and all researchers carrying out the work had
Personal Licences from the UK Home Office. Animals were housed in negative pressure isola-
tors under standard conditions of temperature and humidity. They were monitored daily and
had ad libitum access to feed and water. No mortality occurred and no animal met criteria for
early euthanasia during the study. At the end of the experiment, birds were weighed, anesthe-
tized by CO2 inhalation and euthanized by cervical dislocation. Tissue samples (1g) were col-
lected and placed in RNAlater (Ambion) and stored at 4°C for 24 h followed by long-term
storage at −70°C prior to RNA extraction.
White Leghorn (SPF) chickens hatched from eggs from a CAV-free source, shown to be free
of maternal antibody to CAV as determined by IIF [22], were used throughout this study. Eight
groups of chickens, (n = 6 to 9) housed in separate negative-pressure isolators, were either intra-
muscularly infected at day 1 of age with 0.2 ml of a 106.75 TCID/0.1 ml infective dose of CAV
Cux1 isolate (Cuxhaven-1) or mock infected (MSB1 cells, Marek's disease virus transformed lym-
phoblastoid cell line) as previously described [23–25]. At 4, 7 and 11 dpi, tissues (thymus, spleen,
bursa of Fabricius and bone marrow) were removed from five CAV-infected and five mock-
infected chickens (at 14dpi six animals were sampled from each group) and duplicate samples
taken for microarray and quantitative RT-PCR (qRT-PCR) analyses. A negative control group (4
animals), which were not inoculated, was also included. We have previously observed and con-
firmed that the sequential changes in the lymphoid tissues and organs that follow CAV infection
are highly reproducible, with maximal lymphoid depletion observed at 10–14 days post infection
[15, 24]. Gross pathological examination of animal tissues was performed as previously described
[23, 26] and the results for day 14 when gross lesions were evident, are presented in Table 1. Con-
firmation of viral infection was conducted by immunostaining for CAV antigen using thymus
sections at day 14 using the MAb 2A9 as previously described [24].
RNA extraction and cDNA synthesis
Tissues (30 mg) were homogenised using a bead mill (Retsch, Haan, Germany) and QIAshred-
ders (Qiagen, Crawley, UK). RNA was extracted and purified from homogenates using an
RNeasy mini kit (Qiagen) following the manufacturer’s protocol. cDNA synthesis reactions
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were carried out with 2 μg of total RNA, using Superscript Choice system (Life Technologies,
Paisley, UK) with an oligo (dT) primer containing a T7 RNA polymerase promoter (Research
Genetics, Huntsville, USA). RNA quantity was measured spectrophotometrically and RNA
quality was estimated using an Agilent 2100 Bioanalyser (Agilent Technologies, Waldbronn, 6
Germany). Eluted RNA was stored at -70°C prior to use.
Real-time quantitative RT-PCR
Messenger RNA expression levels were quantified using TaqMan qRT-PCR as described [27–
29]. Primer and probe sequences for cytokine, chemokine and 28S RNA (reference gene)-spe-
cific amplification and three genes that were used for validation of microarray analysis (SLA,
SATB1 and BAK1) are given in Table 2. Probes were all labelled with the fluorescent reporter
dye FAM at the 5’-end and the quencher TAMRA at the 3’-end. Real-time qRT-PCR was per-
formed using the TaqMan Fast universal PCR master mix and one-step RT-PCR master mix
reagents (Applied Biosystems, Cheshire, UK). Amplification and detection of specific products
were performed using the Applied Biosystems 7500 Fast Real-Time PCR System with the fol-
lowing cycle profile: one cycle of 48°C for 30 min and 95°C for 20 s, followed by 40 cycles of
95°C for 3 s and 60°C for 30 s. Results are expressed as 40-Ct, after normalising each sample
using the Ct value for the 28S rRNA product for the same sample, as described previously [27–
29]. Briefly, to account for variation in sampling and RNA preparation, the individual gene
product Ct values were normalised using the Ct value of the 28S rRNA gene product for the
same sample. Normalised Ct were calculated using the formula Ct + (Nt'-Ct')  S/S', where Nt'
is the mean Ct for 28S RNA among all samples, Ct' is the mean Ct for 28S RNA in the sample
and S and S' are the slopes of the regressions of the standard plots for the test mRNA and the
28S RNA, respectively. Results were then expressed as 40-Ct values and converted to fold-dif-
ference (Means are presented in Table 3). Analysis of the difference between transcripts derived
from mock-infected and infected groups was carried out using a nonparametric test (two-sided
Mann-Whitney test) with P<0.05 as significant.
Microarray experiment
RNA preparation and labelling was done as previously described [21]. Cy3 or Cy5 was incorpo-
rated into each RNA sample using the Fairplay labelling kit (Stratagene, La Jolla, CA) and unin-
corporated dyes were removed by passing through DyeEx columns (Qiagen). Dye swap was
used to minimise labelling inefficiencies. Equal proportions of total RNA extracted from all
samples, including from CAV-infected and mock-infected birds, were pooled to create an RNA
Table 1. Pathogenicity evaluations of infected, uninfected andmock-infected animals at day 14 post-infection. Gross pathological examination of
the thymuses and bone marrows was performed in a blind manner, and a clinical score was estimated by scoring the severity of the thymus atrophy and pale-
ness of the bone marrow, as 0, 1 or 2.
Group
description
No. of
chicks
Haematocrit
values
Mean haematocrit
value ± SD
No. of chicks
with anaemia
(%)a
No. of chicks
(score) Bone
Marrow
No. of chicks
(score) Thymus
Mean
Clinical
Score
Infectedb 9 34, 21, 13, 9, 24,
28, 20, 30, 21
22.22 ± 7.93 7 (78) 4 (1), 5 (2) 7 (1), 1 (2) 2.55
Mock- infected
(MSB1 cells)
6 35, 33, 33, 32, 32,
31
32.66 ± 1.37 0(0) None None 0.00
Uninoculated 4 35, 34, 32, 31, 33.00 ± 1.82 0(0) None None 0.00
a Anaemia is deﬁned as a hematocrit value of less than 27.
b The six most affected chicks, based on haematocrit values, were used for microarray analysis.
doi:10.1371/journal.pone.0134866.t001
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Table 2. Real-time quantitative RT-PCR probes and primers.
RNA target Probe/primer sequence (5’-3’)
28S
Probe (FAM)-AGGACCGCTACGGACCTCCACCA-(TAMRA)
F GGCGAAGCCAGAGGAAACT
R GACGACCGATTTGCACGTC
IFN-α
Probe (FAM)-CTCAACCGGATCCACCGCTACACC-(TAMRA)
F GACAGCCAACGCCAAAGC
R GTCGCTGCTGTCCAAGCATT
IFN-β
Probe (FAM)-TTAGCAGCCCACACACTCCAAAACACTG-(TAMRA)
F CCTCCAACACCTCTTCAACATG
R TGGCGTGCGGTCAAT
IFN-γ
Probe (FAM)-TGGCCAAGCTCCCGATGAACGA-(TAMRA)
F GTGAAGAAGGTGAAAGATATCATGGA
R GCTTTGCGCTGGATTCTCA
IL-1β
Probe (FAM)-CCACACTGCAGCTGGAGGAAGCC-(TAMRA)
F GCTCTACATGTCGTGTGTGATGAG
R TGTCGATGTCCCGCATGA
IL-2
Probe (FAM)-ACTGAGACCCAGGAGTGCACCCAGC-(TAMRA)
F TTGGAAAATATCAAGAACAAGATTCATC
R TCCCAGGTAACACTGCAGAGTTT
IL-4
Probe (FAM)-AGCAGCACCTCCCTCAAGGCACC-(TAMRA)
F AACATGCGTCAGCTCCTGAAT
R TCTGCTAGGAACTTCTCCATTGAA
IL-6
Probe (FAM)-AGGAGAAATGCCTGACGAAGCTCTCCA-(TAMRA)
F GCTCGCCGGCTTCGA
R GGTAGGTCTGAAAGGCGAACAG
IL-10
Probe (FAM)-CGACGATGCGGCGCTGTCA-(TAMRA)
F CATGCTGCTGGGCCTGAA
R CGTCTCCTTGATCTGCTTGATG
IL-12α
Probe (FAM)-CCAGCGTCCTCTGCTTCTGCACCTT-(TAMRA)
F TGGCCGCTGCAAACG
R ACCTCTTCAAGGGTGCACTCA
IL-12β
Probe (FAM)-CTGAAAAGCTATAAAGAGCCAAGCAAGACGTTCT-(TAMRA)
F TGGGCAAATGATACGGTCAA
R CAGAGTAGTTCTTTGCCTCACATTTT
IL-13
Probe (FAM-CATTGCAAGGGACCTGCACTCCTCTG-(TAMRA)
F CACCCAGGGCATCCAGAA
R TCCGATCCTTGAAAGCCACTT
CXCLi2
Probe (FAM)-TCTTTACCAGCGTCCTACCTTGCGACA-(TAMRA)
F GCCCTCCTCCTGGTTTCAG
R TGGCACCGCAGCTCATT
TGF-β4
Probe (FAM)-ACCCAAAGGTTATATGGCCAACTTCTGCAT-(TAMRA)
F AGGATCTGCAGTGGAAGTGGAT
R CCCCGGGTTGTGTTGGT
BAK
Probe (FAM)-CCACCATCGCCTCC-(TAMRA)
F CCAAGGAGAACGCCTACGAGTA
R AATGCCGCTGTCGAACAAG
SATB1
Probe (FAM)-ACACCGCCCAGCCGGCCT-(TAMRA)
F GGCCCTGCACCTCTCATAAG
R CTCTCCGTAGCAATAGTAGCAGTTTTG
(Continued)
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pool for use as the reference sample in this experiment. There were three replicates per tissue
sample with the reference sample in the Cy3 channel, and a further three per tissue sample
with the reference sample in the Cy5 channel. Labelling efficiency was determined by running
0.5 μl of each sample on a 1% agarose gel and measuring the intensity of fluorescence on a Gen-
eTac LS iv scanner (Genomic Solutions, Huntingdon, UK). Microarray analysis was conducted
using a chicken immune-targeted cDNA array containing 5190 immune transcripts printed in
duplicate [21]. The clones in the array were derived from normalised cDNA libraries created
from immunologically active tissues such as the bursa of Fabricius, spleen, Peyer’s patch and
thymus (ArrayExpress Acc. No: A-MEXP-307). Microarray hybridisations were carried out
overnight in a GenetAC automated hybridisation system (Genomic Solutions) as previously
described [21]. Original microarray data produced in this study have been deposited according
to the MIAME guidelines in the public database ArrayExpress (http://www.ebi.ac.uk/
microarray-as/ae/) (Acc. No: E-MEXP-1228).
Gene expression data analysis
Dried slides were scanned in a Scanarray 5000 scanner (GSI Lumonics, Rugby, UK) fitted with
Cy3 and Cy5 filters and data were extracted from the slide using BlueFuse software (Blue-
Gnome, Cambridge, UK). Each slide was normalized separately, using all of the log-ratios of
Table 2. (Continued)
RNA target Probe/primer sequence (5’-3’)
SLA
Probe (FAM)-TGCCTTGAAGACTCGTGA-(TAMRA)
F CTCCACGGCAAACCTTTCA
R GACCATCAGCAACTTCTGAGTAGTG
F: forward primer; R: reverse primer.
doi:10.1371/journal.pone.0134866.t002
Table 3. Real-time qRT-PCR cytokine mRNA expression levels following CAV infection in different lymphoid tissues.
Thymus Bone marrow Spleen Bursa of Fabricius
mRNA/day 4 7 11 14 4 7 11 14 4 7 11 14 4 7 11 14
IL-1β 3.741 -5.25 -6.11 - 1.21 -2.73 - -1.78 -4.81 3.24 -2.43 - - -1.39 - -
IL-6 4.89 -5.15 -7.32 -1.54 -1.19 -3.74 -1.29 1.88 -7.97 2.90 -2.69 -5.73 1.68 -1.13 - -1.96
CXCLi2 -1.31 1.62 - - -1.41 1.19 - 2.47 -1.74 -1.99 -2.32 -1.94 1.15 - -8.21 1.21
IFN-α 3.46 -2.52 -4.64 -1.39 -2.22 -1.85 1.41 2.16 -9.95 - -1.72 -4.90 - 1.36 -2.25 -
IFN-β 3.28 -2.94 -8.29 -1.84 -2.02 -1.55 1.61 1.91 -9.57 - -1.70 -4.05 - 1.42 -3.11 -
IL-2 - 11.41 8.66 7.24 1.78 18.53 9.70 -3.08 -1.84 - -2.43 -2.75 - - - -
IL-12α - - - - -7.76 -3.66 - - - 1.37 -1.84 - - - - -
IL-12β - - - 1.69 -1.26 1.30 1.23 -9.57 1.16 -1.48 1.31 -1.48 -2.63 -3.40 - 1.30
IFN-γ 1.21 2.08 2.17 2.40 1.86 - 6.20 -1.25 1.45 - -1.59 -1.15 1.62 -1.98 -1.89 -1.37
IL-4 2.99 -3.57 -7.14 -1.87 1.44 -2.64 -1.29 1.42 -5.31 2.95 -4.35 - - -1.38 -2.09 1.60
IL-13 1.35 1.65 5.36 3.31 6.01 - 15.21 -1.43 -1.24 - - - - - - -
IL-10 - 1.65 4.93 9.75 1.38 1.15 6.30 -1.61 1.30 - - 1.93 - - - -
TGF-β4 -1.14 - 1.92 1.30 - 1.21 1.83 1.15 - - -1.33 -1.18 -1.69 -1.22 2.20 2.55
1Mean fold difference between infected and mock-infected birds at each time-point (n = 5 (6 for d 14)); P<0.05, positive values are up-regulated in infected
birds and negative values are down-regulated in infected birds.—: no signiﬁcant difference between groups or mRNA not expressed in one or both
groups. Changes greater than three-fold are highlighted in bold.
doi:10.1371/journal.pone.0134866.t003
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Cy5 to Cy3 intensities for the non-control spots. Normalization and analysis was based on the
Limma package of Bioconductor [30], with additional plotting from the Bioconductor Marray
package, but with modifications of the Limma models at both normalization and analysis
stages. The normalization was a two-step process of spatial, then intensity-dependent, bias cor-
rection. The spatial bias correction was carried out separately for each 2x2 group of blocks, by
subtracting corresponding row and column means (RC correction, excluding control spots)
from each data spot [31]. The intensity-dependent bias was removed by (local) block-lowess
[32]. The choice of level (global or local) for the two normalization steps was based on the
examination of spatial heat diagrams and MA plots for all four possible normalization combi-
nations. The tissue differences between infected and control samples/birds in their log ratios of
treatment to reference intensities for each gene, taking means of replicate spots on each micro-
array slide, were analysed by regression models. The Limma eBayes correction was used to
shrink the residual variances of genes towards their approximate median value, giving moder-
ated t-tests for the assessment of differential expression [30].
The Benjamini and Hochberg [33] false discovery rate (FDR: the percentage of genes
expected to be wrongly identified as differentially expressed) is the default multiple testing
method in Limma package. Genes with a false discovery rate greater than 5% in either set of
data were excluded from further analysis. No significantly differentially regulated genes were
found in spleen and bone marrow with an FDR<5% and the FDR cut-off was therefore
extended to 20% to identify differentially expressed genes in these tissues. The gene expression
fold change cut-off was set at the customary low threshold of 1.5 to focus more on biologically
significant changes.
Gene Pathway analysis
Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems, Redwood City, CA) was used
to identify biological pathways and functional networks for the identified significantly
expressed genes in thymus. Unigene ID gene identifiers corresponding to these genes were
imported into the IPA program. Each identifier was mapped to its corresponding gene object
in the Ingenuity pathway knowledge base (http://www.ingenuity.com). Differentially expressed
genes within significantly altered pathways were consolidated into interconnected functional
networks and canonical pathways. A score (z) was computed for each functional network, the
negative logarithm of the P value that indicates the likelihood of the focus genes in a network
being found together due to random chance. Scores of z>2 were considered significant, using
a 99% confidence level. The significances for biological functions or canonical pathways were
then assigned to each network by determining a P value for the candidate genes in the func-
tions or pathways networks, compared against the whole Ingenuity pathway knowledge base as
a reference set (S1 File). Right-tailed Fisher’s exact test was used with P<0.05
Results
Cytokine production post-CAV infection
Expression levels of transcripts for the signature pro-inflammatory (IL-1β, IL-6 and CXCLi2),
type I IFN (IFN-α and IFN-β), Th1 (IL-12α, IL-12β and IFN-γ), Th2 (IL-4 and IL-13) and
Treg (IL-10 and TGF-β4) cytokines were measured by qRT-PCR (Table 3). To focus on the
most biologically significant results we will concentrate on differences greater than three-fold
gene expression. Overall, expression was generally unaltered or down-regulated following
infection compared to levels in mock-infected controls except the thymus.
Across the tissues, there was a sustained down-regulation of the innate immune cytokines
with the marked exception of 4 dpi in the thymus. CAV infection induced the pro-
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inflammatory cytokines IL-1β and IL-6 as well as type I IFNs in the infected thymus compared
to mock infected thymus and also compared to the other tissues (Table 3). The up-regulation
of IL-1β and IL-6 in the thymus was also reflected at 7 dpi in the spleen. The levels of the other
pro-inflammatory cytokine measured, CXCLi2, was generally not altered by CAV infection
although it was substantially down-regulated at 11 dpi in the bursa of Fabricius. Of the adaptive
cytokines, only IL-2 showed a sustained and substantial increase in mRNA expression levels
following infection, and only in the thymus and bone marrow. There was little change in the
mRNA levels for the Th1 cytokines, IL-12a and IL-12b, except in the bone marrow where levels
were reduced following infection. Similarly, the Th2 cytokine, IL-4 was mainly down-regulated
across tissues and time. In contrast, the Th1 cytokine, IFN-γ and the Th2 cytokine, IL-13 and
Treg cytokine, IL-10, were all up-regulated in thymus and bone marrow at several time points,
especially at 7 and 11 dpi in the thymus and bone marrow, with similar kinetics to those seen
with IL-2 up-regulation.
Comparison of transcriptomes of immune tissues from mock-infected
and CAV-infected birds, by microarray analysis
This analysis was conducted at 14 dpi when anaemia was gross pathological lesions were evi-
dent (Table 1). The use of an immune-focused array has identified relatively subtle tissue-spe-
cific host gene expression patterns following CAV infection. In terms of FDR and actual
number, most differentially expressed genes were detected in the thymus. A total of 40 genes
were differentially expressed in the thymus (S2 File) with transcription of 21 genes increased
more than 1.5-fold, and transcription of 19 genes decreased more than 1.5-fold compared with
expression levels in mock-infected thymus (see Table 4 for most differentially regulated tran-
scripts in thymus as identified by IPA analysis). Fourteen genes were identified as differentially
regulated in the bone marrow and thirteen in the spleen (S2 File). No significantly differentially
expressed genes were seen in the samples from the bursa of Fabricius.
Differential regulation of genes in response to CAV infection in the
thymus
Gene transcripts which were down-regulated (S2 File) included the Src-like adaptor protein
(SLA), a negative regulator of TCR signalling, Grb-2-related adapter protein (GRAP2), which
is part of the CD28 signalling complex, the CD8α chain precursor and special AT-rich binding
protein 1 (SATB1). Genes up-regulated in the thymus (S2 File) included pro-apoptotic
Bcl2-antagonist killer 1 (BAK1), mucosa-associated lymphoid tissue lymphoma translocation
gene 1 (MALT1), involved in NF-κB activation, fibronectin 1 (FN1), nuclear factor (erythroid-
derived 2)-like 2 (NFEF2L2) and genes encoding immunoglobulin chains (IgA, IgG, IgJ
LV1L2, IgHV and IgHM).
Pathway analysis of genes regulated in the thymus
IPA software was used to identify the main host functions and canonical pathways, from the
microarray data (S2 File), modulated by CAV infection. Differentially-expressed genes in the
thymus fell into diverse functional categories, including cell-cell signalling, immune cell traf-
ficking, inflammatory response, cell death, molecular transport, post-translational modifica-
tion, cellular growth, development and proliferation (S1 File). Of the 34 differentially
modulated canonical pathways that were identified (S1 File), the T-cell receptor (TCR) signal-
ling pathway appeared to be most important for the response of the thymus cells to CAV (P
value: 1.67E-04, Fig 1).
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The most significant CAV-induced gene expression changes were observed in the thymus.
Analysis of expressed genes in the thymus samples of CAV-infected chickens by IPA identified
four gene networks of differentially regulated genes. Gene networks are algorithmically gener-
ated based on their connectivity and ranked based upon a score (S1 File). Fig 2 shows the most
significant gene network (Score = 33), focused on TCR signalling relationships between differ-
entially regulated genes.
Validation of microarray data by qRT-PCR
Microarray data were validated by quantifying the mRNA abundance of selected genes using
TaqMan qRT-PCR. SLA, BAK1 and SATB1 genes were selected among those significantly reg-
ulated and identified by IPA (Fig 2) as significant in CAV infection due to their potential
importance in the T-cell receptor signalling and apoptosis pathways. The qRT-PCR (Table 5)
was consistent with the microarray data (S2 File) including the direction of regulation i.e., up-
regulation or down-regulation, confirming the validity of our data.
Discussion
Hosts typically respond to viral invasion by mounting complex, multifaceted, defensive
immune responses that include substantial induction of type I IFNs, initial production of pro-
Table 4. Most differentially regulated transcripts in thymus as identified by IPAmicroarray analysis.
Symbol Entrez Gene Name Fold
Change
IPA
Networksa
Location Type(s)
MALT1 Mucosa associated lymphoid tissue lymphoma translocation
gene 1
7.359 1 Cytoplasm Peptidase
IGJ Immunoglobulin J polypeptide, linker protein for immunoglobulin
alpha and mu polypeptides
4.845 1 Extracellular
Space
Other
UNG Uracil-DNA glycosylase 3.820 2 Nucleus Enzyme
CWC15 CWC15 spliceosome-associated protein homolog (S.
cerevisiae)
2.829 4 Nucleus Other
FN1 Fibronectin 1 2.635 1 Extracellular
Space
Enzyme
COPE Coatomer protein complex, subunit epsilon 2.601 2 Cytoplasm Transporter
NBL1 Neuroblastoma, suppression of tumorigenicity 1 2.384 2 Nucleus Other
NFE2L2 Nuclear factor (erythroid-derived 2)-like 2 2.133 1 Nucleus Transcription
regulator
BAK1 BCL2-antagonist/killer 1 1.726 1 Cytoplasm Other
COX6A1 cytochrome c oxidase subunit VIa polypeptide 1 -1.643 2 Cytoplasm Enzyme
DDT D-dopachrome tautomerase -1.950 1 Cytoplasm Enzyme
C12H9orf89 Chromosome 12 open reading frame, human C9orf89 -1.998 3 Cytoplasm Other
GRAP2 GRB2-related adaptor protein 2 -2.059 1 Cytoplasm Other
ACOX1 Acyl-CoA oxidase 1, palmitoyl -2.110 1 Cytoplasm Enzyme
PTP4A3 Protein tyrosine phosphatase type IVA, member 3 -2.413 1 Plasma
Membrane
Phosphatase
CD2 CD2 molecule -2.584 1 Plasma
Membrane
Transmembrane
receptor
CD8A CD8a molecule -2.791 1 Plasma
Membrane
Other
SATB1 SATB homeobox 1 -3.233 1 Nucleus Transcription
regulator
SLA Src-like-adaptor -3.521 1 Plasma
Membrane
Other
a Networks identiﬁed by Ingenuity pathway Analysis are included in S1 File.
doi:10.1371/journal.pone.0134866.t004
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inflammatory cytokines to drive Th1 responses with subsequent induction of the relevant Th1
cytokines, later production of anti-inflammatory cytokines to switch off the inflammatory
responses after viral clearance to limit immunopathology and activation of apoptotic pathways.
These are all accompanied by notable changes in gene expression. CAV is an immunosuppres-
sive virus, and is thus thought to interfere in at least some of the host antiviral responses. This
study is the first global, immune-related analysis of the transcriptional response of host cells to
CAV in vivo. Microarray analysis was conducted at 14 dpi when anaemia and gross pathologi-
cal lesions were evident (Table 1) in agreement with previous studies [26, 34]. CAV antigen is
first detected in thymus and bone marrow at days 4–7 days post inoculation in 1-day old
infected chicks. Subsequently it can be found in other tissues but usually within lymphoid tis-
sue [24]. To investigate the lymph tissue tropism of CAV, we decided to sample the bursa of
Fabricius and spleen apart from thymus and bone marrow that are routinely sampled in CAV
studies. The most significant CAV-induced gene expression changes among the tissues tested
Fig 1. Ingenuity pathway analysis showing the most highly scoring canonical pathways (according to P value) associated with the response of
thymocytes to CAV infection. Five pathways had a P value < 0.05. The orange line represents the ratio of the number of differentially expressed thymus
genes in a particular pathway whose expression is correlated with cellular response towards CAV divided by the total number of genes that make up that
pathway. Blue bars represent the P value for each pathway and are expressed as -1 times the log of the P value. The threshold line corresponds to a P value
of 0.05.
doi:10.1371/journal.pone.0134866.g001
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Fig 2. T-cell receptor signalling was the most significant gene network of over-expressed genes in infected samples of thymus as identified by
Ingenuity Pathway Analysis (www.ingenuity.com). Colored nodes represent differentially regulated genes (Table 4) while genes in uncolored nodes were
not identified as differentially expressed and were integrated into the computationally generated network indicating a relevance to it (S1 File). T-cell receptor
signalling gene relationships were overlaid to the network. Solid interconnecting lines represent genes directly connected and dotted lines signify the indirect
connection between genes and cellular functions. Top functions of the genes were related to T-cell receptor signalling, immune response and cellular
assembly and death, identified around the MALT1 gene (in red). Node shapes represent different biological molecules.
doi:10.1371/journal.pone.0134866.g002
Table 5. qRT-PCRmRNA expression levels to confirmmicroarray results following CAV infection in different lymphoid tissues.
Thymus Bone marrow Spleen Bursa of Fabricius
mRNA/day 4 7 11 14 4 7 11 14 4 7 11 14 4 7 11 14
SATB1 1.241 -1.62 -2.77 -7.57 - - - - - - - - - - - -
BAK1 - 1.87 2.34 -3.46 - - - - - - - - - - - -
SLA 1.55 -1.40 -3.92 -4.28 - - - - - - - - - - -1.16 -1.29
1Mean fold difference between infected and mock-infected birds at each time-point (n = 5 (6 for d 14)); P<0.05, positive values are up-regulated in infected
birds and negative values are down-regulated in infected birds.—: no signiﬁcant difference between groups or mRNA not expressed in one or both
groups. Changes greater than three-fold are highlighted in bold.
doi:10.1371/journal.pone.0134866.t005
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in the study, were observed in the thymus, confirming previous reports that the thymus is the
primary target organ for CAV action/infection [35].
Overall, there were no obvious trends in cytokine expression with time that would have
been reflective of anti-viral responses in chickens [27, 36, 37]. Interestingly, at 4 dpi in the thy-
mus, there was evidence of induction of an innate immune response, as mRNA expression lev-
els of the pro-inflammatory cytokines IL-1β and IL-6, and the type I IFNs, IFN-α and IFN- β,
were up-regulated (between 3- and 5-fold). However, these levels of induction were lower than
those seen with other immunosuppressive viral infections, such as infectious bursal disease
virus (IBDV) [27] and Marek’s disease virus [37]. For example, following IBDV infection, IL-
1βmRNA expression levels were up- regulated 10-fold and those of IL-6, 25-fold. Induced
anti-viral innate responses in the chicken normally also involve up-regulation of the IL-8-like
chemokine, CXCLi2 [27, 37], but mRNA expression of this chemokine was slightly down-regu-
lated at 4 dpi. Normally, for a viral infection in the chicken (and of course in mammals), such
an induced innate response would lead to the induction of a Th1-dominated adaptive immune
response, with the production of cytokines such as IL-12 and IFN-γ, from around 5 dpi and
peaking between 7 and 14 dpi. However, following CAV infection, IL-12α expression was not
up-regulated at all and levels of IFN-γ only increased 2-fold at most. In contrast, up-regulation
of IFN-γ by as much as 250-fold was observed following IBDV infection [27] and 25-fold fol-
lowing MDV infection [37]).
However, IL-2 mRNA expression levels were up-regulated from 7–14 dpi, to as high as
11.4-fold, suggesting that there was proliferation of T-cells in response to CAV infection. Fur-
ther evidence of a suppressed Th1 response comes from the levels of expression of IL-13, the
major Th2 cytokine in chickens [28, 36] and the anti-inflammatory IL-10, which were both sig-
nificantly up-regulated at 11 and 14 dpi. However, it should be noted that mRNA expression
levels of the other canonical Th2 cytokine, IL-4, were down-regulated from 7 dpi and those of
the other anti-inflammatory cytokine, TGF-β4, were only slightly up-regulated (less than
2-fold) from 11 dpi.
It thus seems that CAV interferes with the induction of both a full innate response, but cer-
tainly the appropriate Th1 adaptive response, especially since our gross pathological findings
(Table 1) indicated severe viral destruction of the thymus cortex, as has been consistently
reported in CAV studies [4, 9, 38]. In the other lymphoid tissues studied, there was no discern-
ible pattern of cytokine regulation, except for up-regulation of IL-2, IL-10 and IL-13 in the
bone marrow, mirroring what was seen in the thymus. Microarray analyses have not been pre-
viously used to study CAV infection in vivo. For our analyses we used an immunologically rele-
vant focused microarray chip created from a pool of stimulated immune tissues containing
probes of genes that represent a wide spectrum of immune functions [21]. We believe that a
focused array system is preferable to obtain a true transcriptomic representation of a particular
immune phenotype even though that possible regulation of genes involved in non-immune
pathways may be missed. Apart from the obvious technical and economic advantages, focused
arrays may benefit from higher statistical power than universal arrays, by analysis of a consid-
erably smaller dataset and thus eliminating possible masking of data by multiple-testing correc-
tions to the significance levels [39]. The most significant changes in terms of FDR and actual
number of modulated genes were observed in thymus, with fewer in the spleen and the bone
marrow, confirming again that the primary infection site is the thymus [1, 4, 40]. The lack of
gene modulation in the bursa of Fabricius was striking, but not unexpected considering that it
is relatively lacking in T-cells, the primary target cells of CAV infection. The subtle magnitude
of host gene expression differences identified by both qRT-PCR and microarrays and the strin-
gent filtering during array analysis could account for the disparity found for expression levels
of several cytokines between the two assay systems. It is also possible that depleted and
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abundant T cell populations in CAV- and mock- infected respectively thymuses may be at least
partly responsible for the identified microarray transcriptional changes. Nevertheless, the
microarray findings were confirmed by qRT-PCR that is normalized against a reference gene
to compensate for differences in the mRNA template.
As described earlier, VP3 or “apoptin” induces apoptosis in various human tumour and
transformed cells [10, 41, 42]. Apoptin presumably translocates to the nucleus and triggers
apoptosis, via a mechanism that remains largely unknown, but possibly by releasing cyto-
chrome c and other pro-apoptotic mitochondrial proteins from mitochondria [43]. Release of
these proteins is essentially controlled by Bcl-2 family proteins, which include proteins with
both pro- and anti-apoptotic activities [43, 44]. The microarray analyses indicated a marked
up-regulation of mRNA expression levels of the pro-apoptotic Bcl-2 family member Bcl2-anta-
gonist/killer 1 (BAK1). This was confirmed by qRT-PCR (Table 5). This result supports previ-
ous work showing that apoptin-induced cell death is p53-independent and mediated by
members of the Bcl-2 family [41, 45]. Although the exact mechanisms by which Bcl-2 family
members regulate apoptosis are not fully understood, pro-apoptotic Bcl-2 proteins can bind
and deactivate anti-apoptotic proteins, which normally act to preserve mitochondrial mem-
brane integrity and thus prevent the release of cytochrome c [44, 46].
Immune responses to viral antigens can often be disrupted by intrinsic defects in signalling
pathways. Suitable activation and tight regulation of signalling from the TCR are critical for T-
cell development in the thymus, as well as for initiating immune responses in mature T-cells
[47]. Genes involved in TCR signalling and maturation, such as SLA, GRAP2, the CD8α chain
precursor and SATB1, were down-regulated, confirming T-cell dysfunction during CAV infec-
tion. The down-regulation of SLA and SATB1 were also confirmed by qRT-PCR (Table 5).
SLA is a negative regulator of TCR levels during T-cell development [47] and its down-regula-
tion or absence can lead to alterations in T-cell signalling, development and maturation [48–
50]. GRAP2 encodes a protein homologous to human growth factor receptor- binding protein
(GRB2), an adaptor protein that is expressed predominantly in T-cells and acts as a positive
regulator of multiple TCR signalling pathways, including the CD28 complex [51]. GRB2 is also
associated with β-catenin/Wingless (Wnt) protein signalling [52], which plays a major role in
the development of T-cells and the transcription of factors that control the expression of genes
needed for cell growth [53]. Mutations in GRB2 result in impairment of TCR signalling [51].
Similarly, T-cell surface antigen CD2, an adhesion molecule involved, through its interaction
with LFA-3 (CD58), in facilitating CD3/TCR recognition of the antigens presented via the
major histocompatibility complex (MHC) and in T-cell activation [54], was down-regulated in
infected chickens. SATB1 is expressed primarily in thymocytes and in Th2 cells [55] and is a
nuclear protein that binds to the bases of chromatin loop domains and keeps chromatin in
place. It is therefore a likely target for degradation in early apoptosis in order to efficiently dis-
assemble chromatin. SATB1 is also a global regulator, including regulation of expression of the
Th2 cytokines IL-4, IL-5 and IL- 13 [55–57]. It also interacts with Wnt protein signalling [53].
Its marked down- regulation in this experiment may facilitate or reflect apoptosis induced by
CAV. Given the similarities between the regulation of human and chicken TCRs and down-
stream signalling [58], it is reasonable to assume that down-regulation of these genes may
result in deficiencies in TCR signalling in CAV-infected chicken cells. A set of genes involved
mainly in cell signalling and transcription, that includes genes with a likely role in facilitating
or blocking virus propagation, were also differentially regulated following CAV infection.
Up-regulated transcripts included the transcription factor nuclear factor erythroid 2-like 2
(NFEF2L2) in the thymus, the coatomer protein-complex subunit epsilon (COPE) in the bone
marrow and thymus, which is a trafficking protein possibly involved in the transport of viral
proteins [59]. In addition, in the spleen, bone marrow and thymus the paracaspase MALT1, a
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critical mediator of T- and B- cell receptor signalling through cytoplasmic sequestration of Nf-
kB and apoptosis [60], was also notably up-regulated.
The mRNA expression levels of several immunoglobulin chain genes were significantly and
strikingly up-regulated in the thymus following CAV infection (S2 File). This could be due to
an influx of B-cells or activation of B-cells already in the thymus. Upon examination of thymic
sections via immunohistochemistry, we found no evidence of a B-cell influx into the thymus
(data not shown), suggesting a possible activation of thymus-resident B-cells following CAV
infection, perhaps related to the observed up-regulation of IL-10 and IL-13. However, it
remains unclear whether the numerically minor thymic-resident B-cells are truly activated dur-
ing CAV infection and why the B lymphocyte precursors are not affected by CAV.
This study suggests that CAV, like many other viruses obstructs/evades host cellular anti-
viral processes and exploits the host cellular resources to produce viral gene products. The
microarray analyses presented here confirm previous studies that apoptosis occurs following
CAV infection [1, 12, 61], involving the pro-apoptotic Bcl-2 family member Bcl2-antagonist/
killer 1 (BAK1). The combined qRT-PCR and microarray analyses suggest that CAV mediates
immunosuppression by suppressing induced innate (pro-inflammatory) and subsequent adap-
tive responses in T-cells. Virus-induced dysregulation of TCR signalling may also provide a
strategic mechanism for virus escape from the immune system. Parallels occur in other viruses
such as measles virus [62], herpes simplex virus [63] and human T-cell leukaemia/lymphoma
virus type 1 [64], which all inhibit or deregulate TCR signalling. Our data provide novel infor-
mation on key genes to understand CAV pathogenicity and also functional pathway networks
that may inform vaccine strategies. The exact mechanisms by which the viral proteins manipu-
late the TCR and other host signalling pathways, and drive the onset of pro-apoptotic events,
remain to be elucidated.
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